Watermelon lycopene and allied health claims by Naz, Ambreen et al.
EXCLI Journal 2014;13:650-666 – ISSN 1611-2156 
Received: January 20, 2014, accepted: April 17, 2014, published: June 03, 2014 
 
 
 
650 
Review article: 
WATERMELON LYCOPENE AND ALLIED HEALTH CLAIMS 
 
Ambreen Naz*1, Masood Sadiq Butt2, Muhammad Tauseef Sultan3,  
Mir Muhammad Nasir Qayyum4, Rai Shahid Niaz 5 
 
1 Department of Home Economics, Lahore College for Women University, Lahore, Pakistan 
2 National Institute of Food Science and Technology, University of Agriculture, Faisalabad, 
Pakistan 
3 Faculty of Food Science and Technology, University of Putra Malaysia, Malaysia 
4 Department of Food Technology, Karakoram International University, Gilgit-Baltistan,  
Pakistan 
5 Punjab Medical College, Faisalabad, Pakistan 
 
* Corresponding author: e-mail: amber1912@yahoo.com 
 
 
ABSTRACT 
Presently, functional foods and nutraceuticals are gaining immense importance in the preven-
tion of various maladies through dietary regimen module. Consumption of fruits and vegeta-
bles based diet has pursuit a range of bioactive components, especially phytochemicals target-
ing life threatening ailments. In this context, lycopene is an extensively studied antioxidant 
potentially present in watermelon, tomato, pink guava etc. Watermelon is one of the unique 
sources having readily available cis-isomeric lycopene. The distinctive aroma of watermelon 
is imparted by medium- and short-chain fatty acids along with geranial, β-ionone and neral. 
Its consumption has been escalated owing to rich nutritional profile and allied health benefits. 
It is effective in reducing the extent of cancer insurgence, cardiovascular disorders, diabetes 
and macular diseases. The structural characteristics, physiochemical properties and therapeu-
tic effects of lycopene are the limelight of the manuscript. However, further research investi-
gations are still needed to address the health enhancing potential of watermelon lycopene.  
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BACKGROUND 
Accumulating evidences have established 
a consensus that fruits are concentrated 
source of natural components thus having 
health promoting properties (Butt et al., 
2008). Plant based diet contains several bio-
active ingredients with vital role to perform 
various metabolic functions like growth, de-
velopment and protective mechanism against 
physiological threats. In this context, phyto-
chemicals are of significance importance as 
they improve the human health through dis-
tinct pathways. The plants that are rich 
sources of bioactive molecules include gar-
lic, ginger, tea, ginseng, black cumin, mul-
berry, raspberry etc. (Butt et al., 2009). Re-
searchers are focusing on exploitation of 
natural resources for dietary regimen against 
life threatening ailments (Lucier and Lin, 
2001).  
Watermelon (Citrullus lanatus), botani-
cally considered as a fruit, belongs to the 
family Cucurbitaceae (Edwards et al., 2003). 
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It is native to Kalahari desert of Africa but 
nowadays, it is also cultivated in tropical re-
gions of the world. In the pages of history, 
its first harvest was documented 5000 years 
ago in Egypt that later spread to other part of 
the world. Presently, China is the top pro-
ducer followed by Turkey, United States, 
Iran and Republics of Korea (Zohary and 
Hopf, 2000; Lucier and Lin, 2001; Naz et al., 
2013). Watermelon is a valued source of 
natural antioxidants with special reference to 
lycopene, ascorbic acid and citruline. These 
functional ingredients act as protection 
against chronic health problems like cancer 
insurgence and cardiovascular disorders 
(Zhang and Hamauzu, 2004; Omoni and 
Aluko, 2005; Fenko et al., 2009). Lycopene 
is characterized by its distinctive red color in 
fruits and vegetable (Mutanen and Pajari, 
2011). 
During the last few decades, presence of 
appreciable quantity of lycopene in water-
melon has motivated the farmers/growers to 
cultivate high red flesh varieties. Overall, 
twelve hundred cultivars of watermelon are 
produced worldwide while the four most 
promising cultivars are picnic, icebox, yel-
low flesh and seed less (Chalabi et al., 2006; 
Helyes et al., 2009). This review article in-
tends to enlighten the readers regarding rich 
nutritional profile of the watermelon with 
special focus on lycopene and its therapeutic 
aspects like prevent oxidative stress, cancer, 
hypercholesterolemia, diabetes and macular 
disorders. 
 
CLASSIFICATION AND NUTRITION-
AL PROFILE 
Watermelon (Citrullus lanatus) has asso-
ciation with cucumber, pumpkin, squash and 
gourds; belonging to family Cucurbitaceae 
(Edwards et al., 2003). Fruit of this plant is 
major consumed portion and variations in 
growth characteristics determine its end use 
quality (Maynard, 2001; Oms-Oliu et al., 
2009a). Considering the nutritional profile, 
consumption of 100 g watermelon provides 
30 kcal. It contains almost 92 % water and 
7.55 % of carbohydrates out of which 6.2 % 
are sugars and 0.4 % dietary fiber. It is en-
riched with carotenoid, vitamin C, citrulline, 
carotenoids and flavonoids and fat and cho-
lesterol free, thus considered as low caloric 
fruit (Leskovar et al., 2004; Bruton et al., 
2009). Additionally, watermelon is rich 
source of β-carotene acts as an antioxidant 
and precursor of vitamin A.  
Besides the presence of lycopene, it is a 
source of B vitamins, especially B1 and B6, 
as well as minerals such as potassium and 
magnesium (Huh et al., 2008). Watermelon 
contains phenolics quite comparable with 
that of other fruits (Kaur and Kapoor, 2001; 
Jaskani et al., 2005). It is an inexpensive and 
nutritious source that is readily available to 
all socio-economic groups of Pakistan 
throughout the summer season. Its consump-
tion depends on number of factors e.g. avail-
ability, income, age, gender, racial and eth-
nic norms. In this context, per capita con-
sumption in Asian communities is almost 3 
times greater as compared to other part of 
globe (Dermesonlouoglou et al., 2007).  
 
 
BOTANICAL CLASSIFICATION OF 
WATERMELON 
 
Kingdom Plantae – Plant 
Subkingdom Tracheobionta - Vascular plants 
Superdivision Spermatophyta - Seed plants 
Division Magnoliophyta - Flowering plants 
Class Magnoliosida – Dicotyledons 
Order Cucurbit ales 
Family Cucurbitaceae 
Genus Citrullus 
Species Citrullus lanatus 
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AROMA CONTRIBUTING  
VOLATILES 
In various fruits, flowers and spices 
monoterpens and norisoprenoids (apo-
carotenals) are the key compounds produc-
ing characteristic scent. In case of watermel-
on, distinctive aroma is imparted by medi-
um- and short-chain fatty acids along with 
geranial, β-ionone and neral that are some of 
the norisoprenoid and monoterpene com-
pounds. However, esters are absent unlikely 
as in most fruits i.e. strawberry, banana, 
melon etc. (Tadmor et al., 2005). In-vitro ev-
idences have supported that fruit scents are 
degraded carotenoids by the action of lipox-
ygenases, peroxidases and dioxygenases. 
However, it is also interesting to know that 
citral that is an aromatic compound of lemon 
grass, lemon basil and various lemon scented 
plants is a combination cis- and trans- mono-
terpene, neral and geranial. Several gathered 
information have supported its biosynthesis 
in lycopene rich fruits as in watermelon and 
tomato (Micol et al., 2007). 
 
WATERMELON: A POTENTIAL 
SOURCE OF LYCOPENE 
Earlier, only tomato and its products 
were considered as potential sources of lyco-
pene but now there are proven facts that wa-
termelon also contains appreciable amount 
of cis-configured lycopene. Thus consumer 
is gradually shifting towards watermelon and 
its allied products for their health concerns. 
Nevertheless, the quantity of lycopene varies 
depending upon the variety and growing 
conditions (Fish and Davis, 2003). Overall, 
lycopene ranges from 2.30-7.20 mg/100 g 
fresh weight bases, present in crystalline 
form in cell (Huh et al., 2008; Chaoensiri et 
al., 2009; Artes-Henandez et al., 2010). 
More interestingly, lycopene contents of red 
fleshed watermelon are almost 40 % higher 
than tomato i.e. 4.81 and 3.03 mg/100 g, re-
spectively. However, yellow orange and yel-
low colored fleshed have relatively less ly-
copene content i.e. 3.68 and 2.51 mg/100 g, 
respectively (Jaskani, 2005; Choudhary et 
al., 2009). In tomato, lycopene is available in 
relatively higher quantity after heat treatment 
due to break down of protein-carotenoid 
complex. In contrast, lycopene from water-
melon is available directly to the human 
body just after consumption (Edwards et al., 
2003; Perkins-Veaize and Collins, 2004; 
Jaskani et al., 2006; Saftner et al., 2007).  
Storage conditions are also cardinal that 
significantly affect the concentrations of ly-
copene, phenolics and vitamin C contents. 
The higher ratio of lycopene to carotene in 
watermelon i.e. 1:12 yields remarkable anti-
oxidant capacity (Mort et al., 2008). Owing 
to this specific characteristic, foods high in 
lycopene contents are referred as functional 
foods (Shi and Maguer, 2000; Collins et al., 
2005; Jiang and Lin, 2007; Davis et al., 
2008). 
 
SYNTHESIS ROUTE OF LYCOPENE 
A complex mechanism persists in the bi-
osynthesis of lycopene that starts when chlo-
rophyll degrades to yield white colored leu-
coplast thus yielding specialized red color 
pigmented organelles i.e. chromoplast (Bow-
en et al., 2002). Lycopene is a carotenoid 
that is produced as an intermediate product 
of xanthophylls production; β-cryptoxanthin, 
zeaxanthin, leutin etc. Carotenoids are basi-
cally formed by 40-C isoprenoids (5-C iso-
prene unit), called tetraprenoids. A stepwise 
addition of isopentenyl diphosphate (IPP) 
takes place with dimethylallyl diphosphate 
(DMAPP) giving rise 20-C precursor, 
geranylgeranyl diphosphate (GGPP). On de-
saturation of GGPP, 11 conjugated double 
bonds are produced that exist as lycopene in 
nature. From this point cyclic conversion 
takes place converting it to α- and β-carotene 
that on oxidation produce xanthophylls 
(Ishida and Bartley, 2005).  
Lycopene crystals are in voluminous red 
color found in the form of small globules 
suspended throughout the fruit (Chandrika et 
al., 2009). At cellular level lycopene is pre-
sent in thylakoid membrane as protein-
lycopene complex due to its lipophilic na-
ture. It is well documented that lycopene is 
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present in all-trans form within the fruit that 
is transformed from cis-configured lycopene 
due to the action of carotenoid isomerase en-
zyme. However, in case of watermelon ab-
sence of this enzyme keep it in its cis-form 
(Akhtar et al., 1999; Bangalore et al., 2008). 
 
LYCOPENE: STRUCTURE AND PHYS-
ICOCHEMICAL PROPERTIES 
Lycopene is a vibrant tetrapenic carote-
noid with molecular formula of C40H56 (Fig-
ure 1) and contains 11 conjugated and 2 un-
conjugated double bonds (Fish et al., 2002). 
It is an acyclic isomer and open-chain ana-
logue of -carotene that undergoes cis-trans 
isomerization when interact with light, tem-
perature and chemicals (Ollanketo et al., 
2001). A great majority of studies have 
demonstrated that human blood serum con-
tains both cis- and trans- isomeric forms of 
lycopene whereas the plants have only trans- 
configuration except watermelon (Klipstein-
Grobusch et al., 2000; Tadmor et al., 2005). 
Some isomeric forms of lycopene are also 
depicted in Figure 1. Among different con-
figurations, 5-cis form is more stable with 
strong antioxidant potential as compared to 
all-trans, 7-cis, 9-cis, 11-cis, 13-cis and 15-
cis (Arab and Steck, 2000; Chasse et al., 
2001; Lewinsohn et al., 2005; Alquézar et 
al., 2009). 
Numerous publications have reported 
that the amount of lycopene affected signifi-
cantly as a function of storage time and tem-
perature of watermelon. It has been observed 
that the lycopene content at storage tempera-
ture of 5° C varied from 7.8 to 8.1 mg/100 g 
that increased to 8.1 to 12.7 mg/100 g at 
20° C (Mokbe, 2005; Choudhary et al., 
2009). Data from various studies have shown 
an increasing trend of lycopene and -caro-
tene contents of watermelon at higher stor-
age temperatures. It has been suggested that 
the carotenoids producing enzymes pathways 
are sensitive to temperature (Oms-Oliu et al., 
2009b). The details of physical properties of 
lycopene are given in Table 1. 
 
 
 
 
Figure 1: Trans- and cis- isomers of lycopene 
 
 
Table 1: Physical properties of lycopene 
Chemical formula C40H56 
Melting point 172 to 175ºC 
Precipitate form Deep reddish-brown 
Crystalline shape 
Long red needles from a 
mixture of carbon disulfide 
and ethanol 
Sensitivity Light, high temperature, oxygen, acids 
Solubility 
Soluble in non-polar sol-
vents e.g. chloroform,  
hexane 
Insoluble in polar solvents 
i.e. water, methanol and 
ethanol 
(Shi and Maguer, 2000) 
 
ABSORPTION PATHWAY 
Lycopene efficiently absorbs when sup-
plemented with fat owing to its lipophilic 
characteristics (Rao and Agarwal, 1999). Its 
assimilation is dependent on chylomicron 
micells mediated mechanism, facilitates its 
movement from gastrointestinal tract to-
wards body tissues. The isomeric form of ly-
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copene also affects the absorption e.g. trans- 
isomeric form is less adsorbed as compared 
to cis-isomeric configuration (Collins et al., 
2005; Rupasinghe and Clegg, 2007). Presen-
ces of fat as well as cis-isomeric forms facili-
tate lycopene absorption afterwards, it re-
sides in the adipose tissues, liver, prostate 
and adrenal glands. After ingestion of lyco-
pene-based food, disruption carotenoids oc-
cur within the low pH environment of stom-
ach where lycopene get attached to the pro-
tein to pass through intestinal leumen. The 
resultant lycopene-protein complex break-
down and lycopene joins chylomicron in 
blood stream from where it goes to target tis-
sue via hepatic pathway (Jian et al., 2005; 
Gao et al., 2008). The detailed mechanism of 
lycopene absorption and its storage is de-
scribed in Figure 2. 
 
LYCOPENE HEALTH CLAIMS 
Lycopene has potential to prevent vari-
ous chronic ailments like dyslipidemia, dia-
betes, oncogenesis, neurodegenerative dis-
eases, osteoporosis etc. The protective as-
pects are ascribed to the singlet oxygen scav-
enging ability. Numerous metabolic syn-
dromes arise due to high free radicals for-
mation reacting with macromolecules thus 
oxidizing proteins, lipids and DNA. Lyco-
pene protects humans from various patho-
genic attacks responsible for an array of dis-
eases (Ilic and Misso, 2012; Sesso et al., 
2005). Several authors have reported that ly-
copene holds nutraceutical potential and be-
ing antioxidant provides protection against 
free radicals and oxidative damage (Krinsky, 
1998; Rao and Agarwal, 1999; Choksi and 
Joshi, 2007). Free radicals are produced in 
the body during oxidation reduction reaction 
however, excessive production deteriorates 
body defense mechanism, cell membrane 
and organelles. These degenerative processes 
resulted in life threatening ailments (Hum-
berto, 2000; Heber and Lu, 2002; Perkins-
Veazie and Collins, 2006). The presence of 
large number of double bonds is responsible 
for its fairly high free radical scavenging or 
singlet oxygen quenching ability even better 
than α- and β-carotene, lutein and α-toco-
pherol (Rivero et al., 2001; Perkins-Veazie 
and Collins, 2004). Lycopene provides pro-
tection against degenerative disorders via 
mechanisms like gap-junction communica-
tion, gene function regulation, phase II drug-
metabolizing pathways and carcinogenic me-
tabolism (Arab and Steck, 2000; Collins et 
al., 2004). It has been established through 
epidemiological studies that lycopene plays a 
 
 
Figure 2: Absorption pathway of lycopene 
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role in maintaining normal cellular differen-
tiation and division (Giovannucci et al., 
2002; Choudhary et al., 2009). Lycopene 
scavenges free radicals at cellular level due 
to its attachment in cell membrane thereby 
may prevent hypercholesterolemia and hy-
perglycemia along with allied dysfunctions 
(Marinova et al., 2005; Fisher and Frazee, 
2006).  
 
a.Oxidative stress 
Oxidative stress is an etiological factor in 
the onset of various metabolic dysfunctions. 
There are proven facts that uncontrolled oxi-
dation leads to generate excessive reactive 
oxygen species (ROS), causative agent of 
many ailments that can address through anti-
oxidants/phytochemicals rich diets (Butt et 
al., 2009). Excessive production of free radi-
cals leads to atherosclerosis by inactivation 
of nitric oxide and impairment of endotheli-
um dependent vasodilatation. The ROS are 
produced continuously in normal metabolic 
pathways. The diet, smoking, exercises and 
environmental variables may enhance the 
production of ROS (Weisburger, 2002; Espin 
et al., 2007; Migliore and Coppedè, 2009). 
Despite, antioxidants have ability to start re-
pairing through chain-chain interaction with 
oxidized biomolecules (Holden et al., 1999; 
Kauer-Sant'Anna et al., 2009). Diet based 
therapy indicated a significant role of lyco-
pene in the reduction of oxidative damage of 
DNA and lymphocytes and short term im-
provement in LDL oxidation (Alshatwi et al., 
2010). 
The oxidative balance disrupts during 
production of reactive oxygen species (ROS) 
that successively generate double allylic hy-
drogen atom and initiate oxidation of lipid. 
Meanwhile, neutrophils catalyze the synthe-
sis of hypochlorous acid that causes oxida-
tive injury in terms of cellular damage. In 
this milieu, body produces defense enzymes 
i.e. superoxide dismutase (SOD) and gluta-
thione peroxidase (GSH-Px). Superoxide 
dismutase acts as first line defense by pro-
ducing singlet oxygen into hydrogen perox-
ide. However, GSH-Px and catalase enzymes 
convert hydrogen peroxide into water. Gen-
erally, these enzymes work in harmony but 
in case of ROS over production, interruption 
may occur resulting necrosis or apoptosis. In 
such cases, dietary lycopene acts as a thera-
peutic agent to combat excessive ROS pro-
duction (Erdman et al., 2009). 
Oxidative stress plays a vital role in the 
prevalence of chronic diseases. Free radicals 
are linked with various disease pathogenesis 
as diabetes, cardiovascular complications, 
osteoporosis, cancer and cataracts (Ratnam 
et al., 2006). Lycopene significantly restored 
the antioxidant enzymes including glutathi-
one peroxidase (GSH-Px), superoxide dis-
mutase (SOD), reduced glutathione (GSH) 
whilst decreased the levels of lipid peroxide 
malondialdehyde (MDA) in hypertensive pa-
tients (Bose and Agrawal, 2007). Similarly, 
lycopene was found to be effective in reduc-
ing MDA and increasing GSH levels in cor-
onary artery disease (Misra et al., 2006). 
Later, Kim et al. (2011) examined the effect 
of lycopene in smoker men with low fruit 
and vegetable intake through a double blind 
randomized controlled study. They conclud-
ed that lycopene significantly reduces oxida-
tive stress and ameliorates endothelial func-
tion (Pennathur et al., 2010). 
Likewise, Dogukan et al. (2011) probed 
lycopene against cisplatin-induced lipid pe-
roxidation and nephrotoxicity in male wistar 
rats. A significant decrease in renal bax pro-
tein was observed in rats administrated on 
lycopene; an indicator of low oxidative 
stress. Earlier, Devaraj et al. (2008) deter-
mined the response of lycopene supplemen-
tation on oxidative stress markers. For the 
reason, human subjects were provided lyco-
pene for two months following LDL and 
MDA assessment. Lymphocytes were also 
analyzed to observe any deleterious effect. 
Comparison of subjects with lycopene re-
stricted group showed a marked decrease in 
LDL oxidation and TBAR value i.e. 17 and 
21 %, respectively. Previous literature has 
delineated the protective role of lycopene 
rich food against DNA damage in normal 
and cancer cells (Liu et al., 2005; Scolastici 
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et al., 2008). Likewise, a reduction in lipid 
peroxidation products i.e. TBARS (21 %) 
and DNA damage markers were observed in 
the fibroblast of monkey. In case of rats, ly-
copene injection for five days with a dose 
level 10 mg/kg/day showed reduction in lipid 
peroxidation and prostate tissue protection 
against Fe-induced oxidative damage (Matos 
et al., 2006). 
Various interventional studies have de-
scribed the interaction between reduced 
dyslipidemia and lycopene consumption. 
The lycopene rich diets have potential to re-
duce lipid peroxidation, one of the leading 
factors of hypercholesterolemia. In a case 
study, Mackinnon et al. (2011) noticed an 
inverse association of dietary lycopene with 
oxidative stress and positive impact on bone 
integrity. Effect of no lycopene diet was de-
termined in postmenopausal women of 50 to 
60 years. Blood serum was analyzed for pro-
tein thiols and thiobarbituric-malondialde-
hyde reactive substances along with bone 
turn over markers; alkaline phosphatase and 
cross-linked N-telopeptide. Inferences of re-
search indicated that dietary restrictions of 
lycopene for one month resulting tremen-
dous increase in oxidative stress biomarkers 
with allied bone resorption. 
Similarly, a study was conducted in hu-
man subjects to find out the role of lycopene 
enriched functional juice and vitamin C. The 
core objective was to measure the effect of 
lycopene (20.6 mg/day) and vitamin C (435 
mg/day) against the biomarkers of inflamma-
tion and oxidative stress. Blood serum was 
examined for lipid status, TBAR and antiox-
idant capacity. The decrease in TBAR (19 to 
22 %) and rise in glutathione value (17 to 
20 %) was recorded. It has been observed 
that functional juice led to a decline in total 
cholesterol (Jacob et al., 2008). A complete-
ly randomized cross over study was conduct-
ed to probe the role of lycopene in suppres-
sion of oxidative stress using lycopene based 
capsules. Purposely, twelve healthy subjects 
were administrated on these capsules and a 
reduction in lipid oxidation was observed. 
The oxidative stress biomarkers i.e. TBAR 
and glutathione showed significant changes. 
The glutathione value raised up to 23.6 %, 
whereas, a decrease of 20 % in TBAR value 
was noticed (Rao and Shen, 2002). Lycopene 
attenuates lifestyle related disorders without 
imparting any deleterious effects on hemato-
logical aspects. Accordingly, Jonker et al. 
(2003) conducted a three months study to in-
vestigate any toxic effect of lycopene in 
wistar rats. Blood assay was performed to 
evaluate the red and white blood cell count, 
hemoglobin, thrombocytes, neutrophils, 
lymphocytes and monocytes. The summary 
of hematological aspects revealed non-
significant effect of lycopene supplementa-
tion. Moreover, histopathological examina-
tion did not reflect any adverse sign. The 
health benefits of lycopene are depicted in 
Figure 3. 
 
b. Nutrigenomics and cancer insurgence 
Presently, a number of evidences are availa-
ble indicating direct linkages between food 
active components and cell genomic with 
special reference to cancer treatment. Nutri-
genomics is a broader term that explains in-
teraction of nutrient with gene expression. 
Being active dietary component, lycopene 
interferes at various stages of cancer devel-
opment i.e. DNA mutation and tumor metas-
tasis thus have direct impact on gene and in-
hibit mutation (Nahum et al., 2001). Howev-
er, understanding of lycopene and gene in-
teraction has not yet been well established 
and needs further research. Lycopene is like-
ly to be associated in the production of phase 
I and II enzymes that are essential for me-
tabolism of carcinogen within the physiolog-
ical system. Phase I enzyme has potential to 
activate the carcinogen whilst phase II en-
zyme is responsible for attaching polar group 
to the activated carcinogen that facilitates its 
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Figure 3: Health benefits of lycopene 
 
excretion. Furthermore, it activates antioxi-
dant response element transcription system 
within the body to inhibit carcinogenesis, 
mutagenesis and some other forms of toxici-
ty (Linnewiel et al., 2009; Butt et al., 2013). 
Lycopene is a viable antioxidant and be-
yond this property also attributed for its anti-
proliferative effects against oncological inci-
dences. Its functionality is associated in di-
minishing the insulin growth factor thus 
lowering rate of cancer prevalence. Re-
searchers have unified their opinions on in-
verse association between blood lycopene 
level and risk of various cancer types. This 
individualized approach is also supported by 
mechanistic exploration with different cell 
cultures and animal models (Fenko et al., 
2009). It has direct relation with phase I and 
II enzymes and also protects cell membrane, 
DNA and other macromolecules by reactive 
oxygen species. Furthermore, it is involved 
in regression of cancer by interrupting cancer 
cell growth cycle, apoptosis, hormone regu-
lation and carcinogen metabolism (Butt et 
al., 2013).  
Numerous case studies have indicated 
chemopreventive role of lycopene regarding 
aerodigestive tract cancers (oral cavity, 
pharynx, larynx and esophagus). According-
ly, an oncological efficacy trial was carried 
out on hamster buccal pouch carcinogenesis 
induced by 7, 12-dimethylbenz anthracene 
using lipid peroxidation, glutathione reduc-
tase and glutathione S-transferase as bio-
markers of chemoprevention. After 2 weeks, 
biochemical measurements revealed modu-
lating effect of lycopene against buccal 
pouch cancer and enhancing activities of glu-
tathione redox cycle enzymes (Bhuvaneswari 
et al., 2001). In a similar study, combined ef-
fect of lycopene, vitamin C, flavonoids and 
phytosterols was established in the regres-
sion of aerodigestive tract carcinoma (Stefani 
et al., 2000).  
Colorectal cancer is one of most preva-
lent malignancy related to colon. Many type 
of tumorogenesis are accelerated by phos-
phatidylinositol 3-kinase (PI-3K)/Akt path-
way that in turn stimulates transcription and 
protein translation, essential for cell growth, 
survival and progression. Cumulative evi-
dences suggested that lycopene could sup-
press proliferation of colon cancer through 
modulation of PI-3k. For the purpose, con-
comitant effect of lycopene and eicosapen-
taenoic acid (EPA) was determined in human 
subjects. It was observed that combination of 
lycopene and EPA inhibit cell growth at 
higher concentration and somehow reduce at 
low concentration (Tang et al., 2009). Previ-
ous studies have reinforced lycopene associ-
ation with reduced cancer risk. A case study 
on colorectal cancer explicated that the pa-
tients with colorectal adenomas (a type of 
polyp proved as precursor of colorectal can-
cer) had significant lower level of lycopene 
(35 %) as well as -carotene (25.5 %) com-
pared to healthy adults. Administration of 
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lycopene at early stages has ability to slow 
down cancer cell progression (Slattery et al., 
2000).  
It has been reported from the research in 
the Harvard University that the subjects con-
suming appreciable dosage of lycopene have 
resistance against various cancer lines espe-
cially prostrate (Dahan et al., 2008). An in-
verse correlation exists between the con-
sumption of high lycopene and prostate can-
cer as observed through a research interven-
tion. Men with high consumption of lyco-
pene in diet reported 25 % less incidences of 
prostate cancer and overall 44 % reduced 
risk of other cancers (Tang, 2009). Accord-
ing to Ansari et al. (2004), lycopene therapy 
has an effective role in the prevention of 
hormone refractory metastatic prostate can-
cer. In current frantic incidences of cancer, 
lycopene must be administrated at early on-
set of prostate cancer due to its relative in-
nocuous nature rather than chemotherapy 
and growth factor inhibitors. Afterwards, 
Kanagaraj et al. (2007) reviewed lycopene 
impact on the components of insulin growth 
factors (IGF); found a significant decrease in 
the proliferation of cells treated with lyco-
pene.  
Carcinomas of breast, ovary and endo-
metrium are hormone dependent and have 
some biological similarities. Numerous epi-
demiological studies have presumed that diet 
and nutrition play a preventive role in pro-
gression of hormone related cancer milieu. 
Chalabi et al. (2004) studied breast cancer 
lines for BRCA1 and BRCA2 for transcrip-
tion and translation. According to their find-
ings, lycopene dietary sources have direct re-
lation on oncogenesis and developed nutri-
genomic link of lycopene. It was hypothe-
sized that lycopene derivatives may act as 
ligands and regress tumorogenesis. Likewise, 
females consuming ample amount of water-
melon have five times less likely risk of cer-
vical cancer (Rao et al., 2007; Wu et al., 
2007; Moussa et al., 2008). The cascade of 
events is due to high anti-proliferative pro-
perties of lycopene as compared to α- and β- 
carotene (Levi et al., 2001). Lycopene also 
hold the ability to control autocrine and 
paracrine system a contributory factor in the 
development of the endometrial cancers and 
malignant tumors (Salman et al., 2007). 
 
c. Cardiovascular complications 
Cardiovascular diseases (CVD) is con-
tributed by sedentary lifestyle and reported 
as a leading cause of mortality. Cardiac risk 
is elevated due to consumption of high cho-
lesterol diet resulting subacute chronic in-
flammation. Distinctively, LDL-cholesterol, 
serum amyloid A (SAA) and inter-cellular 
adhesion molecule (ICMA-1) are the risk 
factors thereby facilitate atherosclerosis pro-
gression and cardiovascular events (Ver-
schuren et al., 2011). 
Hypercholesterolemia is a condition in 
which serum lipid level increases especially 
cholesterol and low density lipoproteins 
(LDL) that further leads to atherosclerosis. 
Dietary lycopene exert cardio-protective ef-
fects due to their high antioxidant activity 
(Cauza et al., 2004). Apart from lipid lower-
ing drug therapy, dietary interventions are 
encouraged to attenuate hypercholesterole-
mia. For the purpose, fifty-six Albino male 
rats were administrated on tomato lycopene 
for 10 weeks. The resultant data indicated 
that the rats fed on hypercholesterolemic diet 
induced significant increase in serum total 
lipid level, total cholesterol, low and high 
density lipoprotein and decreased levels of 
glutathione peroxidase and malonaldehyde. 
On the contrary, diet having tomato lycopene 
mitigated the signs and symptoms of hyper-
cholesterolemia (Basuny et al., 2009). In an-
other research, impact of lycopene was stud-
ied on macrophages. The derived results 
demonstrated that macrophages enrichment 
with lycopene potentially suppressed cellular 
cholesterol synthesis and ameliorated mac-
rophages LDL receptor ability. This effect 
can lead to enhanced clearance of LDL from 
the plasma thus lycopene is recognized as 
hypocholesterolemic agent (Fuhrman et al., 
1997). 
The watermelon is also helpful to lessen 
some other metabolic syndromes owing to 
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vitamin A, B6, C, magnesium, potassium. 
These along with lycopene are health pro-
moting functional ingredients associated 
with reduced risk of cardiovascular disor-
ders. Heart attacks, ischemic strokes and ath-
erosclerosis are faced through the oxidation 
of low density lipoprotein and their curing 
has been observed though high consumption 
of lycopene (Omoni and Aluko, 2005). High 
intake of lycopene lowered the thickness of 
the internal layer of the blood vessels thus 
reducing the risk of myocardial infarction 
(Zhang and Hamauzu, 2004). Consumption 
of watermelon is more advantageous as ly-
copene is readily available through water-
melon (Rao and Agarwal, 1999; Weisburger, 
2002). 
 
d. Diabetes mellitus 
Numerous experimental studies and sur-
veys have indicated that patients with hyper-
glycemia are more prone towards the risk of 
coronary complications. In this context, ele-
vated oxidative stress and LDL oxidation are 
the major contributory factors. High glyce-
mic diet significantly elevates glucose and its 
auto-oxidation consequently generates free 
radicals and cell damage (Micol et al., 2007). 
Besides, Sugiura et al. (2006) explored phe-
nolics i.e. lycopene, lutein, β-carotene, β-
cryptoxanthin and β-carotene for their hypo-
glycemic action. The upshots of the research 
showed an inverse association of carotenoids 
with serum aminotransferases in hypergly-
cemic subjects. Among all, lycopene is 
proved as deterrent constituent against serum 
aminotransferases and significantly prevents 
the onset of hyperglycemia. Additionally, 
oxidative stress is increased during hyper-
glycemia phase through intracellular reactive 
oxygen species (ROS). As a result of this 
imbalance inside the cell ROS damages the 
mitochondria, DNA, lipids and other orga-
nelles leading to apoptosis. Investigation of 
Micol et al. (2007) also proved hypoglyce-
mic perspectives of lycopene and elucidated 
that watermelon lycopene extract significant-
ly improves lipid and glycemic metabolism. 
Recent research studies have marked 
obesity and diabetes as the major public 
health problems in most of the countries. The 
diabetes prevalence is so high and estimated 
that its level raised from 135 to 300 million 
by the years 1995 to 2025 (American Diabe-
tes Association, 2007). During the progres-
sion of obesity, adipokines (cytokines and 
chimiokines) are synthesized that play an 
important role in general body physiology. 
Massive development of adipose tissue leads 
to inflammation resulting from the excessive 
production of chimiokines and cytokines 
thus leading to type II diabetes. Lycopene is 
a lipophilic carotenoid stored in adipose tis-
sues thereby reduces the pathologies linked 
with obesity and hyperglycemic conditions 
(Madhava et al., 2011). 
The lycopene based functional drinks 
have potential to reduce malignant transfor-
mation of oxidized cholesterol in diabetic 
state. The lycopene decreases diabetes in lin-
ear fashion by managing glucose abnormali-
ties. Lycopene owes ability to decrease body 
glucose and raise insulin level in type II dia-
betes. In an investigation, Jian et al. (2008) 
studied the impact of oral supplementation of 
lycopene in normal rats for twenty eight 
days. The lycopene was daily supplied in 
doses as 0, 200, 500 and 2000 mg/kg body 
weight by gavage. No significant signs of 
abnormality were noticed for hematology, 
urinalysis and organs weight. However, a 
decline in glucose value was observed at 
higher lycopene dose. The significant differ-
ences in body glucose were noted between 
control and lycopene treated rats i.e. 205.6 ± 
44.3 and 132.1 ± 35.9 mg/dL, respectively. 
Conclusively, they confirmed lycopene as an 
ameliorating factor for hyperglycemia. 
Alongside, substantial studies have re-
vealed negative association of hyperglyce-
mia with the central nervous system (CNS), 
leads to cognitive dysfunction. High intracel-
lular glucose level induces learning and 
memory impairments and neurochemical and 
structural abnormalities. In a rat modeling, 
provision of lycopene supplemented diet 
ameliorates cholinergic dysfunction, cogni-
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tive deficit nitric oxide and reduces oxidative 
stress. Moreover, a marked decline in serum 
glucose level was observed i.e. 5 % after 4 
mg/day supplementation of lycopene (Kuhad 
et al., 2008). Clinical findings also delineat-
ed lycopene a good option for the develop-
ment of functional foods owing to its hypo-
glycemic perspectives. In this context, 
Mellert et al. (2002) conducted a thirteen 
days study on normal wistar rats to judge the 
lycopene response. They deduced that lyco-
pene interim supplementation significantly 
reduces body glucose level i.e. 13 %. 
Watermelon extract is considered as a 
concentrated source of nutrients along with 
lycopene. In a trial, 1 % extract was adminis-
tered to the diabetic rats. At the termination 
of study, rise in insulin level 37 % whilst de-
cline in glucose 33 % were observed. The 
study indicated watermelon extract as a hy-
perinsulinemic and hypoglycemic product 
(Ahn et al., 2011). In a nested case control 
trial, data were collected for diabetic middle 
aged women from a period of 1992 to 2003 
to find out the association of dietary lyco-
pene intake with insulin level. During ten 
years of follow up, observed cases depicted a 
linear correlation between lycopene and in-
sulin level and a rise of 37-45 % was no-
ticed. The wide range of variations was at-
tributed to the altered body metabolism of 
diabetic patients. The findings reflected ly-
copene ability to improve insulin sensitivity 
and glucose metabolism (Wang et al., 2006). 
There are some convincing epidemiolog-
ical evidences in favor of lycopene, vitamin 
E and vitamin C with decreased incidence of 
cardiovascular complications in diabetic pa-
tients. Accordingly, a study was conducted 
by Upritchard et al. (2000) to determine the 
effect of lycopene and vitamin E and C on 
LDL oxidation and inflammatory activity in 
type II diabetes. Initially, 57 diabetic patients 
received functional juice as a source of die-
tary lycopene (500 mL/day) along with vit-
amin E (800 U/day) and vitamin C (500 
mg/day). The results indicated that high in-
take of lycopene and vitamin C and E are 
one of the options to reduce various coronary 
complications in diabetic patients. Likewise, 
lycopene dose dependent effect was estimat-
ed in streptozotocin (STZ) induced hyper-
glycemic rats to find its potential against hy-
perglycemia, hyperlipidemia and abnormal 
antioxidant status. Furthermore, results were 
compared with hyperglycemic and normo-
glycemic rat groups. A dose dependent de-
crease in glucose level and TBAR along with 
rise in insulin value was noticed. The inves-
tigation elucidated antidiabetic activity of ly-
copene by lowering free radicals (Ali and 
Agha, 2009). 
Diabetes based neuronal abnormalities 
are attributed to the high intracellular glu-
cose. Effect of lycopene was determined 
with special reference to its antioxidative and 
anti-inflammatory behavior on oxidative 
stress, cognitive function and inflammation 
in streptozotocin (STZ) induced diabetic rats. 
During the ailment, acetyl cholinesterase ac-
tivity, a biomarker of cholinergic dysfunc-
tion increased in cerebral cortex of diabetic 
rats about 1.8 fold. Moreover, a rise in thio-
barbituric acid reactive substances was about 
2 folds. It was concluded that lycopene has 
ability to mitigate cognitive deficit, inflam-
mation and oxidative stress in diabetic rats 
(Kuhad et al., 2008). 
Hyperalgesia is a neuropathic pain in di-
abetes because of microvascular complica-
tions. An investigation performed by Kuhad 
et al. (2008) has revealed the therapeutic role 
of watermelon lycopene against neuropathic 
pain associated with diabetes. Additionally, 
lycopene has ability to reverse the hyperal-
gesic stage to some extent. Similarly, role of 
lycopene as an antioxidant was assessed in 
streptozotocin (STZ) induced diabetic rats, 
In this regard, 6 female rats received 
10 mg/kg body weight lycopene once a day 
for three weeks. Diabetes induction caused 
significant rise in serum glucose and reduc-
tion in body weight. However, lycopene 
showed assuaging effect on diabetic rats by 
reducing serum glucose level up to 25 %. 
Weight loss was also prevented after two 
weeks of lycopene administration. Conclu-
sively, lycopene supplementation proved 
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valuable to combat against hyperglycemia 
(Duzguner et al., 2008). 
 
e. Macular diseases 
Macular degenerative disease onsets with 
the thinning of macula layer of retina thereby 
resulting in gradual decrease in vision. The 
symptoms include appearance of yellow 
spots (Bramley, 2000). There are two types 
of age related macular degeneration (AMD) 
including wet and dry. However, dry AMD 
is more prevalent further in turns to wet 
AMD when new blood vessels develop to 
reduce the dryness of macular layer. The de-
velopment of such vessels favors hemor-
rhage, swelling, and scar on the eye tissue 
(Bazzano et al., 2002). The utilization of ca-
rotenoids or their rich sources can reduce the 
risk of macular and other degenerative disor-
ders. In an experimental study of macula-
degeneration, subjects with low lycopene-
serum concentrations were at high risk. Ly-
copene is also effective against immunodefi-
ciency diseases like HIV and cerebral dam-
age microangiopathy in Austrian stroke (Kun 
et al., 2006).  
 
CONCLUSIONS 
Watermelon is a proven distinctive 
source of lycopene claiming new era vitamin 
due to health promising properties. Diversi-
fied nature of watermelon lycopene has at-
tained core attention of researchers in terms 
of bioavailability and absorption. Safe and 
sound extraction procedure with minimal 
loss is desirable at industrial scale. Finally, 
available information from numerous cell 
culture and animal models have illuminated 
the therapeutic role of lycopene against life 
threatening metabolic syndromes like oxida-
tive stress, cancer, CVD, diabetes etc. Never-
theless, still there is a need for dietary inter-
vention for better understanding of role of 
lycopene on human health.  
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